Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV
Background & Aims: Accurate HDV RNA quantification is crucial for diagnosis and management of chronic hepatitis delta (CHD), yet a significant variability between assays exists. We compared three methods to quantify HDV RNA levels in untreated and bulevirtide (BLV)-treated patients with CHD....
Saved in:
| Main Authors: | Maria Paola Anolli, Sara Uceda Renteria, Elisabetta Degasperi, Floriana Facchetti, Dana Sambarino, Marta Borghi, Riccardo Perbellini, Roberta Soffredini, Sara Monico, Annapaola Callegaro, Pietro Lampertico |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | JHEP Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555924003033 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving Virological Monitoring of HDV Infection: A Proof-of-Concept Comparative Study of Bosphore and AltoStar<sup>®</sup> Assays in Patients Treated with Bulevirtide
by: Verdiana Zulian, et al.
Published: (2025-06-01) -
Current and future therapeutic options for chronic hepatitis D virus infection
by: Mariantonietta Pisaturo, et al.
Published: (2025-02-01) -
HBV, HCV, and HDV Triple-Infection—A Therapeutic Challenge
by: Alexia Anastasia Stefania Balta, et al.
Published: (2025-05-01) -
Results of HDV RNA detection in male seminal fluid and female cervical swab samples using RT-PCR
by: Saruul Enkhjargal, et al.
Published: (2023-12-01) -
Pharmacotherapy of hepatitis D: the current and the future
by: George Sarin Zacharia, et al.
Published: (2025-05-01)